Header Logo

Connection

LORETTA NASTOUPIL to Interleukin-15

Back to Details
This is a "connection" page, showing publications LORETTA NASTOUPIL has written about Interleukin-15.
LORETTA NASTOUPIL
Connection Strength
0.054
Interleukin-15
  1. Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial. Nat Med. 2024 Mar; 30(3):772-784.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.